GlassScriptPhysician profile
Timotea Lara
NPI 1053659961
$1,551.00
in general payments reported to CMS, 2019-2025
18 companies · $766 in 2025
The $766 reported for 2025 was more than what 81% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $410 · 2022: $190 · 2023: $165 · 2024: $19.95 · 2025: $766.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $951.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $950.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $244.22 | 2024-2025 | |
| Daiichi Sankyo INC. | $175.26 | 2025 | Enhertu |
| Jazz Pharmaceuticals INC. | $150.00 | 2022 | |
| Myriad Genetic Laboratories, INC. | $141.22 | 2023 | Prolaris |
| Novocure INC. | $130.81 | 2021-2023 | Optune |
| Genzyme Corporation | $124.98 | 2021 | |
| Genentech USA, INC. | $106.64 | 2021 | |
| Ipsen Biopharmaceuticals, INC | $86.22 | 2025 | Onivyde |
| Tersera Therapeutics LLC | $67.74 | 2025 | Zoladex |
| Novartis Pharmaceuticals Corporation | $58.70 | 2025 | |
| Caris Mpi, INC. | $48.71 | 2025 | Mi Cancer Seek |
| Ge Healthcare | $47.38 | 2021 | |
| Astellas Pharma US INC | $39.95 | 2022 | |
| Abbvie INC. | $33.02 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $31.41 | 2025 | Enhertu |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $23.89 | 2021 | |
| Merck Sharp & Dohme LLC | $22.30 | 2025 | Keytruda |
| Immunitybio, INC. | $18.55 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timotea Lara listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.